相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Lentiviral vectors and cardiovascular diseases: a genetic tool for manipulating cardiomyocyte differentiation and function
E. Di Pasquale et al.
GENE THERAPY (2012)
Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations
Daniela Cesana et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts
Arianna Moiani et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Lentiviral Vector Induced Insertional Haploinsufficiency of Ebf1 Causes Murine Leukemia
Dirk Heckl et al.
MOLECULAR THERAPY (2012)
Retroviral Integrations in Gene Therapy Trials
Luca Biasco et al.
MOLECULAR THERAPY (2012)
Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection
Alessandra Biffi et al.
BLOOD (2011)
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure
Mariell Jessup et al.
CIRCULATION (2011)
Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell
Luca Biasco et al.
EMBO MOLECULAR MEDICINE (2011)
Promoter-specific lentivectors for long-term, cardiac-directed therapy of Fabry disease
Chyan-Jang Lee et al.
JOURNAL OF CARDIOLOGY (2011)
In Vitro DNA Tethering of HIV-1 lntegrase by the Transcriptional Coactivator LEDGF/p75
Melissa McNeely et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Lentiviral Vector Integration Profiles Differ in Rodent Postmitotic Tissues
Cynthia C. Bartholomae et al.
MOLECULAR THERAPY (2011)
Comparative Genomic Integration Profiling of Sleeping Beauty Transposons Mobilized With High Efficacy From Integrase-defective Lentiviral Vectors in Primary Human Cells
Brian Moldt et al.
MOLECULAR THERAPY (2011)
The transcriptional co-activator LEDGF/p75 displays a dynamic scan-and-lock mechanism for chromatin tethering
Jelle Hendrix et al.
NUCLEIC ACIDS RESEARCH (2011)
Nuclear protein LEDGF/p75 recognizes supercoiled DNA by a novel DNA-binding domain
Kimiko M. Tsutsui et al.
NUCLEIC ACIDS RESEARCH (2011)
Different Behaviors of Retroviral Gene Transfer Vectors
Alessandro Ambrosi et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
HIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2
Karen E. Ocwieja et al.
PLOS PATHOGENS (2011)
Modification of Integration Site Preferences of an HIV-1-Based Vector by Expression of a Novel Synthetic Protein
Robert M. Silvers et al.
HUMAN GENE THERAPY (2010)
Production of HIV-1 Integrase Fusion Protein-Carrying Lentiviral Vectors for Gene Therapy and Protein Transduction
Diana Schenkwein et al.
HUMAN GENE THERAPY (2010)
LEDGF Hybrids Efficiently Retarget Lentiviral Integration Into Heterochromatin
Rik Gijsbers et al.
MOLECULAR THERAPY (2010)
Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency
Salima Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
High-resolution profiling of the LEDGF/p75 chromatin interaction in the ENCODE region
Jan De Rijck et al.
NUCLEIC ACIDS RESEARCH (2010)
Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration
Andrea L. Ferris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Elevated Oxidative Membrane Damage Associated with Genetic Modifiers of Lyst-Mutant Phenotypes
Colleen M. Trantow et al.
PLOS GENETICS (2010)
HIV integration site distributions in resting and activated CD4+ T cells infected in culture
Troy Brady et al.
AIDS (2009)
Acute Toxicity Study of a Simian Immunodeficiency Virus-Based Lentiviral Vector for Retinal Gene Transfer in Nonhuman Primates
Yasuhiro Ikeda et al.
HUMAN GENE THERAPY (2009)
The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy
Eugenio Montini et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Analysis of Lentiviral Vector Integration in HIV plus Study Subjects Receiving Autologous Infusions of Gene Modified CD4+T Cells
Gary P. Wang et al.
MOLECULAR THERAPY (2009)
Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott-Aldrich Syndrome in Preclinical Models
Francesco Marangoni et al.
MOLECULAR THERAPY (2009)
Hybrid Lentivirus-transposon Vectors With a Random Integration Profile in Human Cells
Nicklas H. Staunstrup et al.
MOLECULAR THERAPY (2009)
Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors
Ute Modlich et al.
MOLECULAR THERAPY (2009)
Sleeping Beauty Transposition From Nonintegrating Lentivirus
Conrad A. Vink et al.
MOLECULAR THERAPY (2009)
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency.
Alessandro Aiuti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Nathalie Cartier et al.
SCIENCE (2009)
Massively parallel pyrosequencing in HIV research
Frederic D. Bushman et al.
AIDS (2008)
Transportin-SR2 imports HIV into the nucleus
Frauke Christ et al.
CURRENT BIOLOGY (2008)
Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders
Cecilia Lundberg et al.
CURRENT GENE THERAPY (2008)
Integration site selection by retroviral vectors: Molecular mechanism and clinical consequences
Rene Daniel et al.
HUMAN GENE THERAPY (2008)
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
Steven J. Howe et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Salima Hacein-Bey-Abina et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16
U. Modlich et al.
LEUKEMIA (2008)
Safety and efficacy of gene transfer for Leber's congenital amaurosis
Albert M. Maguire et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
HIV-1 Pre-Integration Complexes Selectively Target Decondensed Chromatin in the Nuclear Periphery
Alberto Albanese et al.
PLOS ONE (2008)
The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication
Alan Engelman et al.
PLOS PATHOGENS (2008)
Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting
Heather M. Marshall et al.
PLOS ONE (2007)
Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery
Angelo Lombardo et al.
NATURE BIOTECHNOLOGY (2007)
HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications
Gary P. Wang et al.
GENOME RESEARCH (2007)
LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration
Ming-Chieh Shun et al.
GENES & DEVELOPMENT (2007)
Retroviral vector insertion sites associated with dominant hematopoietic clones mark stemness pathways
Olga S. Kustikova et al.
BLOOD (2007)
Gene transfer in humans using a conditionally replicating lentiviral vector
Bruce L. Levine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Selection of target sites for mobile DNA integration in the human genome
Charles Berry et al.
PLOS COMPUTATIONAL BIOLOGY (2006)
Integration site choice of a feline immunodeficiency virus vector
Yubin Kang et al.
JOURNAL OF VIROLOGY (2006)
HIV integration site selection: Targeting in macrophages and the effects of different routes of viral entry
Stephen D. Barr et al.
MOLECULAR THERAPY (2006)
Gene therapy progress and prospects: the eye
J. W. B. Bainbridge et al.
GENE THERAPY (2006)
Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75
Manuel Llano et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor
Simon F. De Meyer et al.
BLOOD (2006)
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration
Eugenio Montini et al.
NATURE BIOTECHNOLOGY (2006)
Integration site selection by and growth-arrested HIV-Based vectors in dividing IMR-90 lung fibroblasts
A Ciuffi et al.
MOLECULAR THERAPY (2006)
A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo
F Turlure et al.
NUCLEIC ACIDS RESEARCH (2006)
Lentivirus-mediated gene transfer to the central nervous system: Therapeutic and research applications
LF Wong et al.
HUMAN GENE THERAPY (2006)
A role for LEDGF/p75 in targeting HIV DNA integration
A Ciuffi et al.
NATURE MEDICINE (2005)
Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1
B Crise et al.
JOURNAL OF VIROLOGY (2005)
Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication
S Emiliani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding
K Busschots et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Symmetrical base preferences surrounding HIV-1 and avian sarcoma/leukosis virus but not murine leukemia virus integration sites
AG Holman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses
XL Wu et al.
JOURNAL OF VIROLOGY (2005)
Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy
M Tschernutter et al.
GENE THERAPY (2005)
Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells
M De Palma et al.
BLOOD (2005)
Regulatory considerations for novel gene therapy products: A review of the process leading to the first clinical lentiviral vector
P Manilla et al.
HUMAN GENE THERAPY (2005)
LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes
M Llano et al.
JOURNAL OF VIROLOGY (2004)
Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences
RS Mitchell et al.
PLOS BIOLOGY (2004)
Integrase-specific enhancement and suppression of retroviral DNA integration by compacted chromatin structure in vitro
KD Taganov et al.
JOURNAL OF VIROLOGY (2004)
Genome-wide analyses of avian sarcoma virus integration sites
A Narezkina et al.
JOURNAL OF VIROLOGY (2004)
Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer
J Seppen et al.
MOLECULAR THERAPY (2003)
Transcription start regions in the human genome are favored targets for MLV integration
XL Wu et al.
SCIENCE (2003)
HIV-1 integration in the human genome favors active genes and local hotspots
ARW Schröder et al.
CELL (2002)
LEDGF, a survival factor, activates stress-related genes
T Shinohara et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2002)
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Correct integration mediated by integrase-LexA fusion proteins incorporated into HIV-1
ML Holmes-Son et al.
MOLECULAR THERAPY (2002)
Lentiviral vector gene transfer into fetal rhesus monkeys (Macaca mulatta):: Lung-targeting approaches
AF Tarantal et al.
MOLECULAR THERAPY (2001)
LEDGF binds to heat shock and stress-related element to activate the expression of stress-related genes
DP Singh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo
GP Kobinger et al.
NATURE BIOTECHNOLOGY (2001)